Tight Five: World Rugby's referee crisis – fast-tracking or failing standards?
OPINION: World Rugby trials new referees, but high standards remain a pressing concern.
AdvertisementAdvertise with NZME.
Latest from Premium
Oceania Healthcare records $17.1m interim loss, sells properties
Firm selling older rest homes to put money into more upmarket villages, fancy care suites.
Joanna Wane: Every time you don’t wash your dishes, god kills a kitten
OPINION: In the office kitchen wars, nothing is off the table.
A2 Milk rallies sharply on dividend news
Concerns about China cast a shadow over share price.
Mass X-odus: Professionals desert Elon Musk’s network
Financial Times: ‘Sewage prioritised' in decline of X as freelancers flee the platform.
Ex-Breakfast host given payout - TVNZ wins early legal battle; Failed TV firm owes bank $8.56m; Is TradeMe set to be sold?
Is TradeMe about to be traded?; Top ad execs' new outdoor business; Big Stuff changes.
Gregor Paul: Playing it safe or playing it smart? Razor's selection dilemma
OPINION: Why the All Blacks' strong line-up against Italy might be a double-edged sword.
Billionaire Adani charged in US over alleged $425m bribery scheme
Financial Times: Tycoon and others accused of lying to land lucrative contracts.
Wellington Airport’s big runway project set to shake up international travel
The runway will be able to handle direct flights to Asia in a $500m redevelopment.
One NZ gears up for SpaceX’s Starlink Direct to Cell - what to expect
Direct to Cell communication would be a 'game-changer'.
Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.
Editorial: Why we need to look past a 'survive till 25' mentality
Economic recovery is coming but won't solve structural problems.
How Kamala Harris burned through $2.5b in 15 weeks
NY Times: Was investing in celebrity-fuelled events more ostentatious than effective?
One NZ and Space X's 'celltower in the sky partnership' - how it will work
It's the final countdown: One NZ CEO Jason Paris on what to expect from his firm's high-stakes hookup with Elon Musk's SpaceX. Video / Dean Purcell
The truth about hot showers: Benefits and hidden risks
'A hot bath or shower should be a treat, not a daily occurrence.'
Letters: I can't lead a hīkoi for healthcare, I can barely walk
OPINION: 'Please Mayor, abolish AT and reform the other CCOs just as soon as you can.'
New Zealand’s top young executives - where are they now?
Where the Deloitte Top 200 Young Executive winners have ended up.
Matthew Hooton: Luxon completely out of his depth
OPINION: From economy to race relations to health, the PM has failed the leadership test.
Ex-Breakfast host given payout; TVNZ wins early legal battle
'I can imagine people being outraged that TVNZ signed a deal with me.'
'We’re not going to be a slave to a surplus' - Associate Finance Minister
Expectations tempered around return to surplus in 2027/28.
Market close: NZ stocks recover to make small gain
Investors are waiting for next week's pivotal interest rate decision.
Wellington jobless numbers steady despite Govt cuts
Official stats show unemployment has fallen in the capital as other areas rise.
Why Sharon Horgan returned to Bad Sisters after its perfect ending
Horgan’s critically acclaimed Bad Sisters continues with new challenges for the Garveys.
Zespri improves most fruit returns outlook but net profit forecast down
Zespri must sell 190 million trays of kiwifruit from record crop.
Mansons TCLM to build $90m, six-level Remuera medical hub
Other large healthcare hubs near the site include Southern Cross and Auckland Eye.
David Seymour says he lacks confidence in early analysis of Waikato Med School merits
The Act leader provided his own analysis to prove his point.
Sports Insider: It was no knockout but Netflix lands big punch in streaming wars
OPINION: TikTok disrupts the sports scene, targeting youth with Messi and more.
Councils in growth areas given green light to borrow more
New pathway created for councils to lift debt caps.
Why do we cry? The science behind human tears explained
NY Times: We’re the only species that sheds emotional tears, but reasons remain an enigma.
Fonterra's consumer business sale and how it might look
Lack of capital for the FMCG operation is not the only reason for Fonterra's exit.
Case against real estate boss follows ruling against ex-Harcourts agent
'This case didn’t get elevated to the top. I accept it should have.' - Cooper
Audrey Young: Shallow takes on Treaty hīkoi underestimate its power
OPINION: Change is coming – whether critics like it or not.
Cher can, and does, turn back time in new memoir
New York Times: Cher's new memoir explores her difficult childhood and fraught marriage.
Nvidia revenue nearly doubles as AI chip demand remains strong
Financial Times: Analysts watch how new chips affect short-term growth.